Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer

Malavaud, 2004, T1G3 bladder tumours: the case for radical cystectomy, Eur Urol, 45, 406, 10.1016/j.eururo.2003.11.007

Shariat, 2010, The effect of age and gender on bladder cancer: a critical review of the literature, BJU Int, 105, 300, 10.1111/j.1464-410X.2009.09076.x

Kamat, 2015, Expert consensus document: consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer, Nat Rev Urol, 12, 225, 10.1038/nrurol.2015.58

Jimenez, 2000, Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival, Am J Surg Pathol, 24, 980, 10.1097/00000478-200007000-00009

Pellucchi, 2015, Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer: a step forward or back?, BJU Int, 115, 267, 10.1111/bju.12666

Nigwekar, 2008, The many faces of urothelial carcinoma: an update with an emphasis on recently described variants, Adv Anat Pathol, 15, 218, 10.1097/PAP.0b013e31817d79b9

Park, 2008, Prognostic significance of non-papillary tumor morphology as a predictor of cancer progression and survival in patients with primary T1G3 bladder cancer, World J Urol, 27, 277, 10.1007/s00345-008-0350-4

Tilki, 2013, Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy, BJU Int, 111, 1215, 10.1111/j.1464-410X.2012.11455.x

Yafi, 2014, Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer, World J Urol, 32, 1295, 10.1007/s00345-013-1207-z

Chade, 2010, Clinical outcome of primary versus secondary bladder carcinoma in situ, J Urol, 184, 464, 10.1016/j.juro.2010.03.134

Amin, 2015, Update for the practicing pathologist: the International Consultation on Urologic Disease-European Association of Urology consultation on bladder cancer, Mod Pathol, 28, 612, 10.1038/modpathol.2014.158

van der Aa, 2005, A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation, Hum Pathol, 36, 981, 10.1016/j.humpath.2005.06.017

Paner, 2007, Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma, Am J Surg Pathol, 31, 1420, 10.1097/PAS.0b013e3180588283

Orsola, 2005, Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients, Eur Urol, 48, 231, 10.1016/j.eururo.2005.04.013

van Rhijn, 2012, A new and highly prognostic system to discern T1 bladder cancer substage, Eur Urol, 61, 378, 10.1016/j.eururo.2011.10.026

Bertz, 2011, Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series, Histopathology, 59, 722, 10.1111/j.1365-2559.2011.03989.x

Chang, 2012, Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection, Am J Surg Pathol, 36, 454, 10.1097/PAS.0b013e31823dafd3

Brimo, 2013, Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion, Hum Pathol, 44, 95, 10.1016/j.humpath.2012.04.020

van der Meijden, 2000, The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials, J Urol, 164, 1533, 10.1016/S0022-5347(05)67022-X

Bol, 2003, Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder, J Urol, 169, 1291, 10.1097/01.ju.0000055471.78783.ae

Compérat E1, 2013, An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps, Histopathology, 63, 756, 10.1111/his.12214

Sfakianos, 2014, The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin, J Urol, 191, 341, 10.1016/j.juro.2013.08.022

Martin-Doyle, 2015, Improving selection criteria for early cystectomy in high-grade T1 bladder cancer: a meta-analysis of 15,215 patients, J Clin Oncol, 33, 643, 10.1200/JCO.2014.57.6967

Cheng, 1999, Predicting cancer progression in patients with stage T1 bladder carcinoma, J Clin Oncol, 17, 3182, 10.1200/JCO.1999.17.10.3182

Cottrell, 2007, Consistency of microstaging pT1 bladder transitional cell carcinoma, J Clin Pathol, 60, 735, 10.1136/jcp.2006.045708

Orsola, 2010, Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR, BJU Int, 105, 202, 10.1111/j.1464-410X.2009.08694.x

Fransen van de Putte, 2015, Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder, Curr Opin Urol, 25, 427, 10.1097/MOU.0000000000000202

Orsola, 2015, Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients, Br J Cancer, 112, 468, 10.1038/bjc.2014.633